Pulmonx Corporation Common Stock (LUNG) is a publicly traded Healthcare sector company. As of October 27, 2026, LUNG trades at $2.24 with a market cap of $83.75M and a P/E ratio of -1.59. LUNG moved +1.54% today. Year to date, LUNG is -13.91%; over the trailing twelve months it is +26.92%. Its 52-week range spans $1.13 to $8.12. Analyst consensus is strong buy with an average price target of $3.50. Rallies surfaces LUNG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LUNG, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.24 |
| Market Cap | $83.75M |
| P/E Ratio | -1.59 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.12 |
| 52-Week Low | $1.13 |
| Volume | 271.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $87.44M |
| Net Income | $-48.12M |
| Gross Margin | 77.06% |
4 analysts cover LUNG: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.50.